Stephen J Teach1, Peter J Gergen2, Stanley J Szefler3, Herman E Mitchell4, Agustin Calatroni4, Jeremy Wildfire4, Gordon R Bloomberg5, Carolyn M Kercsmar6, Andrew H Liu7, Melanie M Makhija8, Elizabeth Matsui9, Wayne Morgan10, George O'Connor11, William W Busse12. 1. Children's National Health System and the George Washington University School of Medicine and Health Sciences, Washington, DC. Electronic address: steach@childrensnational.org. 2. National Institute of Allergy and Infectious Diseases, Bethesda, Md. 3. Children's Hospital Colorado and University of Colorado Denver School of Medicine, Aurora, Colo. 4. Rho Federal Systems Division, Chapel Hill, NC. 5. Washington University School of Medicine, St Louis, Mo. 6. Cincinnati Children's Hospital, Cincinnati, Ohio. 7. National Jewish Health, Denver, and Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo. 8. Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill. 9. Johns Hopkins University School of Medicine, Baltimore, Md. 10. University of Arizona College of Medicine, Tucson, Ariz. 11. Boston University School of Medicine, Boston, Mass. 12. University of Wisconsin School of Medicine and Public Health, Madison, Wis.
Abstract
BACKGROUND: Asthma exacerbations remain common, even in children and adolescents, despite optimal medical management. Identification of host risk factors for exacerbations is incomplete, particularly for seasonal episodes. OBJECTIVE: We sought to define host risk factors for asthma exacerbations unique to their season of occurrence. METHODS: This is a retrospective analysis of patients aged 6 to 20 years who comprised the control groups of the Asthma Control Evaluation study and the Inner City Anti-IgE Therapy for Asthma study. Univariate and multivariate models were constructed to determine whether patients' demographic and historical factors, allergic sensitization, fraction of exhaled nitric oxide values, spirometric measurements, asthma control, and treatment requirements were associated with seasonal exacerbations. RESULTS: The analysis included 400 patients (54.5% male; 59.0% African American; median age, 13 years). Exacerbations occurred in 37.5% of participants over the periods of observation and were most common in the fall (28.8% of participants). In univariate analysis impaired pulmonary function was significantly associated with greater odds of exacerbations for all seasons, as was an exacerbation in the previous season for all seasons except spring. In multivariate analysis exacerbation in the previous season was the strongest predictor in fall and winter, whereas a higher requirement for inhaled corticosteroids was the strongest predictor in spring and summer. The multivariate models had the best predictive power for fall exacerbations (30.5% variance attributed). CONCLUSIONS: Among a large cohort of inner-city children with asthma, patients' risk factors for exacerbation vary by season. Thus information on individual patients might be beneficial in strategies to prevent these seasonal events.
BACKGROUND:Asthma exacerbations remain common, even in children and adolescents, despite optimal medical management. Identification of host risk factors for exacerbations is incomplete, particularly for seasonal episodes. OBJECTIVE: We sought to define host risk factors for asthma exacerbations unique to their season of occurrence. METHODS: This is a retrospective analysis of patients aged 6 to 20 years who comprised the control groups of the Asthma Control Evaluation study and the Inner City Anti-IgE Therapy for Asthma study. Univariate and multivariate models were constructed to determine whether patients' demographic and historical factors, allergic sensitization, fraction of exhaled nitric oxide values, spirometric measurements, asthma control, and treatment requirements were associated with seasonal exacerbations. RESULTS: The analysis included 400 patients (54.5% male; 59.0% African American; median age, 13 years). Exacerbations occurred in 37.5% of participants over the periods of observation and were most common in the fall (28.8% of participants). In univariate analysis impaired pulmonary function was significantly associated with greater odds of exacerbations for all seasons, as was an exacerbation in the previous season for all seasons except spring. In multivariate analysis exacerbation in the previous season was the strongest predictor in fall and winter, whereas a higher requirement for inhaled corticosteroids was the strongest predictor in spring and summer. The multivariate models had the best predictive power for fall exacerbations (30.5% variance attributed). CONCLUSIONS: Among a large cohort of inner-city children with asthma, patients' risk factors for exacerbation vary by season. Thus information on individual patients might be beneficial in strategies to prevent these seasonal events.
Authors: Stanley J Szefler; Herman Mitchell; Christine A Sorkness; Peter J Gergen; George T O'Connor; Wayne J Morgan; Meyer Kattan; Jacqueline A Pongracic; Stephen J Teach; Gordon R Bloomberg; Peyton A Eggleston; Rebecca S Gruchalla; Carolyn M Kercsmar; Andrew H Liu; Jeremy J Wildfire; Matthew D Curry; William W Busse Journal: Lancet Date: 2008-09-20 Impact factor: 79.321
Authors: John V Williams; James E Crowe; Rachel Enriquez; Patricia Minton; R Stokes Peebles; Robert G Hamilton; Stanley Higgins; Marie Griffin; Tina V Hartert Journal: J Infect Dis Date: 2005-08-29 Impact factor: 5.226
Authors: Christine A Sorkness; Robert F Lemanske; David T Mauger; Susan J Boehmer; Vernon M Chinchilli; Fernando D Martinez; Robert C Strunk; Stanley J Szefler; Robert S Zeiger; Leonard B Bacharier; Gordon R Bloomberg; Ronina A Covar; Theresa W Guilbert; Gregory Heldt; Gary Larsen; Michael H Mellon; Wayne J Morgan; Mark H Moss; Joseph D Spahn; Lynn M Taussig Journal: J Allergy Clin Immunol Date: 2006-11-30 Impact factor: 10.793
Authors: Tmirah Haselkorn; Robert S Zeiger; Bradley E Chipps; David R Mink; Stanley J Szefler; F Estelle R Simons; Marc Massanari; James E Fish Journal: J Allergy Clin Immunol Date: 2009-11 Impact factor: 10.793
Authors: Ronina A Covar; Stanley J Szefler; Robert S Zeiger; Christine A Sorkness; Mark Moss; David T Mauger; Susan J Boehmer; Robert C Strunk; Fernando D Martinez; Lynn M Taussig Journal: J Allergy Clin Immunol Date: 2008-10 Impact factor: 10.793
Authors: Nino Khetsuriani; N Neely Kazerouni; Dean D Erdman; Xiaoyan Lu; Stephen C Redd; Larry J Anderson; W Gerald Teague Journal: J Allergy Clin Immunol Date: 2006-11-30 Impact factor: 10.793
Authors: Alkis Togias; Peter J Gergen; Jack W Hu; Denise C Babineau; Robert A Wood; Robyn T Cohen; Melanie M Makhija; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Rebecca S Gruchalla; Andrew H Liu; Emily Wang; Haejin Kim; Carin I Lamm; Leonard B Bacharier; Dinesh Pillai; Steve M Sigelman; James E Gern; William W Busse Journal: J Allergy Clin Immunol Date: 2018-09-11 Impact factor: 10.793
Authors: Stephen J Teach; Michelle A Gill; Alkis Togias; Christine A Sorkness; Samuel J Arbes; Agustin Calatroni; Jeremy J Wildfire; Peter J Gergen; Robyn T Cohen; Jacqueline A Pongracic; Carolyn M Kercsmar; Gurjit K Khurana Hershey; Rebecca S Gruchalla; Andrew H Liu; Edward M Zoratti; Meyer Kattan; Kristine A Grindle; James E Gern; William W Busse; Stanley J Szefler Journal: J Allergy Clin Immunol Date: 2015-10-27 Impact factor: 10.793
Authors: William T Shearer; Denise L Jacobson; Wendy Yu; George K Siberry; Murli Purswani; Suzanne Siminski; Laurie Butler; Erin Leister; Gwendolyn Scott; Russell B Van Dyke; Ram Yogev; Mary E Paul; Ana Puga; Andrew A Colin; Meyer Kattan Journal: J Allergy Clin Immunol Date: 2017-03-06 Impact factor: 10.793
Authors: Wilson Quezada; Eun Soo Kwak; Joan Reibman; Linda Rogers; John Mastronarde; William G Teague; Christine Wei; Janet T Holbrook; Emily DiMango Journal: Ann Allergy Asthma Immunol Date: 2015-12-19 Impact factor: 6.347
Authors: Michelle A Gill; Andrew H Liu; Agustin Calatroni; Rebecca Z Krouse; Baomei Shao; Allison Schiltz; James E Gern; Alkis Togias; William W Busse Journal: J Allergy Clin Immunol Date: 2017-09-01 Impact factor: 10.793
Authors: Jeffery M Franklin; Jocelyn R Grunwell; Alice C Bruce; Robin C Smith; Anne M Fitzpatrick Journal: Ann Allergy Asthma Immunol Date: 2017-05-04 Impact factor: 6.347
Authors: Shona Fielding; Marielle Pijnenburg; Johan C de Jongste; Katharine C Pike; Graham Roberts; Helen Petsky; Anne B Chang; Maria Fritsch; Thomas Frischer; Stanley Szefler; Peter Gergen; Francoise Vermeulen; Robin Vael; Steve Turner Journal: Chest Date: 2018-10-22 Impact factor: 9.410